Granupas Marketing Halt: Implications for Tuberculosis Treatment
An unexpected decision by Eurocept International B.V. to cease the commercial distribution of Granupas (aminosalicylic acid) marks a significant turning point in therapies aimed...
EMA’s Strategic Engagement: Industry Insights and Forward-Looking Recommendations
Stakeholder interactions and clear communication channels are vital for the European Medicines Agency's (EMA) continued success in advocating for innovative and high-quality medicinal solutions...
NECA Announces 2026 Patient-Centered Healthcare Research Opportunities
Driving innovation in patient-centered healthcare, the Korea Health Industry Development Institute (NECA) opens applications for its 2026 research projects until January 30th. These initiatives...
Early Treatment Response to Vunakizumab Boosts Long-Term Outcomes in Plaque Psoriasis
In a groundbreaking analysis that holds promise for people grappling with plaque psoriasis, researchers dive into the effects of early response to a therapeutic...
Exdensur: A New Hope for Severe Asthma and CRSwNP in Japan
A significant milestone has been reached in the treatment options available for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in Japan. GSK's...
Telemedicine Flexibilities Extended to Sustain Critical Access
As the landscape of healthcare continues to move towards digitalization, the seamless provision of services becomes an imperative challenge. On January 2, 2026, the...
Spinal Cord Rehabilitation Boosts Independence in SCI Patients
A remarkable initiative at a leading Swiss rehabilitation clinic has yielded significant progress for individuals facing the challenges of spinal cord injuries and diseases....
Genomic Epidemiology Workshop Empowers Scientific and Public Health Dialogues
In the wake of the COVID-19 pandemic, the importance of genomic epidemiology stands clearer than ever. This innovative field, by tracking the evolution and...
Ramping Up TB Screening for Vulnerable Migrant Populations
In many parts of the world, tuberculosis (TB) continues to be a formidable adversary, especially for migrants, refugees, and stateless individuals (MRS). These groups...
GSK’s Nucala Gains Approval in China for Advanced COPD Treatment
The latest approval of GSK’s Nucala marks a significant milestone in China's healthcare landscape. As a nation grappling with chronic obstructive pulmonary disease (COPD),...
Sanofi Pioneers Priority Review for Tzield in Young Diabetes Patients
Sanofi surges forward in the field of immunotherapy as the US FDA grants priority review to their innovative drug, Tzield (teplizumab-mzwv). Tzield targets young...
Tislelizumab Fails to Deliver Significant Benefits for Nasopharyngeal Carcinoma Patients
In a comprehensive evaluation overseen by the Institute for Quality and Efficiency in Health Care (IQWiG) in Germany, the therapeutic potential of Tislelizumab in...
FDA Report Highlights Data Gaps in PFAS Safety for Cosmetics
In a significant move, the U.S. Food and Drug Administration (FDA) has unveiled a critical report concerning the use of perfluoroalkyl and polyfluoroalkyl substances...
UCB Pushes Digital Health Adoption for Epilepsy Care Progress
UCB hosted its third Epilepsy Digital Roundtable on December 3, 2025, marking a significant commitment towards enhancing patient outcomes through digital health initiatives. The...
Pregnancy and Diabetes: Navigating the Glycemic Challenges with Technology
Pregnancy often poses unique glycemic challenges for women with pregestational diabetes, heightening the importance of effective management strategies. As insulin resistance escalates after the...
